Increased plasma fatty acid clearance, not fatty acid concentration, is associated with muscle insulin resistance in people with obesity

Metabolism. 2022 Jul:132:155216. doi: 10.1016/j.metabol.2022.155216. Epub 2022 May 13.

Abstract

Background: Although it is well-accepted that increased plasma free fatty acid (FFA) concentration causes lipid overload and muscle insulin resistance in people with obesity, plasma FFA concentration poorly predicts insulin-resistant glucose metabolism. It has been proposed that hyperinsulinemia in people with obesity sufficiently inhibits adipose tissue triglyceride lipolysis to prevent FFA-induced insulin resistance. However, we hypothesized enhanced FFA clearance in people with obesity, compared with lean people, prevents a marked increase in plasma FFA even when FFA appearance is high.

Methods: We assessed FFA kinetics during basal conditions and during a hyperinsulinemic-euglycemic clamp procedure in 14 lean people and 46 people with obesity by using [13C]palmitate tracer infusion. Insulin-stimulated muscle glucose uptake rate was evaluated by dynamic PET-imaging of skeletal muscles after [18F]fluorodeoxyglucose injection.

Results: Plasma FFA clearance was accelerated in participants with obesity and correlated negatively with muscle insulin sensitivity without a difference between lean and obese participants. Furthermore, insulin infusion increased FFA clearance and the increase was greater in obese than lean participants.

Conclusions: Our findings suggest plasma FFA extraction efficiency, not just plasma FFA concentration, is an important determinant of the cellular fatty acid load and the stimulatory effect of insulin on FFA clearance counteracts some of its antilipolytic effect.

Trial registration: ClinicalTrials.gov NCT02994459 NCT03408613.

Keywords: Adipose tissue; Fatty acids; Insulin resistance; Obesity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Fatty Acids / metabolism
  • Fatty Acids, Nonesterified
  • Glucose / metabolism
  • Humans
  • Insulin / metabolism
  • Insulin Resistance* / physiology
  • Kinetics
  • Muscle, Skeletal / metabolism
  • Obesity / metabolism

Substances

  • Fatty Acids
  • Fatty Acids, Nonesterified
  • Insulin
  • Glucose

Associated data

  • ClinicalTrials.gov/NCT02994459
  • ClinicalTrials.gov/NCT03408613